Healthcare

The Biotech Revaluation Is On

By

Jim Cramer

 | Apr 17, 2013 | 6:20 AM EDT

These four names in particular have made some stunning moves.

A Growing Biotech Sees Hedge-Fund Buying

By

Meena Krishnamsetty

 | Apr 16, 2013 | 6:30 PM EDT

Santarus gets a cash infusion from Visium Asset Management.

Weighing a Trade in Mettler-Toledo

By

Paul Price

 | Apr 16, 2013 | 10:00 AM EDT

Take advantage of a pullback to pick up a high-quality stock at a great price.

Health Care Stocks Still Promising

By

Kate Stalter

 | Apr 11, 2013 | 10:24 AM EDT

Plenty of leadership remains in the health care sector and there’s reason to see further potential.

Consider Playing Catch-Up Via Biotech

By

Jim Cramer

 | Apr 10, 2013 | 3:32 PM EDT

Deep-in-the-money call options on these five names could provide a healthy return.

C.R. Bard Illustrates a Point

By

Robert Moreno

 | Apr 4, 2013 | 1:41 PM EDT

Occasionally there is unusual technical synchronization on multiple timeframes.

Merck on the Move

By

Gary Morrow

 | Apr 3, 2013 | 12:00 PM EDT

The stock is leaving behind this short-term base.

Another Biotech Play

By

Timothy Collins

 | Mar 28, 2013 | 3:35 PM EDT

Keep this one on the radar for a pullback buying opportunity.

Ready to Roll With ONYX

By

Timothy Collins

 | Mar 28, 2013 | 12:01 PM EDT

Feeling good about the biotechs.

Two Long Setups in the Pharma Sector

By

Robert Moreno

 | Mar 11, 2013 | 2:12 PM EDT

Charts of Actavis and Alexion show a combination of positive technical factors.

Columnist Conversation / Market Updates

NetApp (NTAP): Storing Up Disappointment
By

Chris Laudani

 | May 21, 2013 | 5:33 PM EDT
Co misses on revenues. Revenue rose (if you can call it that) 0.8% to $1.7 bin. (I was looking for 1.7% y/y rev growth.)...

Making a late move on NTAP
By

Robert Lang

 | May 21, 2013 | 3:46 PM EDT
We added a call spread for NTAP here, not as pricey as the move implies, the chart not looking too bad. I like this for...
See more »

Our Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.